Trametinib, dabrafenib strike at BRAF-mutant disease: Commentary

Jeffrey A. Sosman*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Trametinib, dabrafenib strike at BRAF-mutant disease: Commentary'. Together they form a unique fingerprint.